CONSENT TO ASSIGNMENTConsent to Assignment • March 18th, 2008 • Transition Therapeutics Inc. • Medicinal chemicals & botanical products
COLLABORATION AGREEMENT Between WARATAH PHARMACEUTICALS INC. And ELAN PHARMA INTERNATIONAL LIMITED September 25, 2006Collaboration Agreement • March 18th, 2008 • Transition Therapeutics Inc. • Medicinal chemicals & botanical products • New York
This COLLABORATION AGREEMENT (this “Agreement”) is entered into as of September 25, 2006, by and between Waratah Pharmaceuticals Inc. a company with offices at Suite 220, 101 College Street, Toronto, Ontario, M5G 1L7 (“WARATAH”), and Elan Pharma International Limited, a private company limited by shares organized under the laws of Ireland with offices at Monksland, Athlone, County Westmeath, Ireland (“ELAN”). Each of ELAN and WARATAH is sometimes referred to individually herein as a “Party” and are sometimes referred to collectively as the “Parties.”
LICENSE AGREEMENTLicense Agreement • March 18th, 2008 • Transition Therapeutics Inc. • Medicinal chemicals & botanical products • Ontario
THIS AGREEMENT is entered into as of May 28, 2003 (the “Effective Date”) by and between ELLIPSIS BIOTHERAPEUTICS CORP. (“Ellipsis”), having its principal offices at 700 Bay St. Suite 2101, Toronto, ON M5G 1Z6 and JOANNE MCLAURIN, PHD (“the Licensor”), of 181 Mortimer Avenue, Toronto, ON, M4J 2C4. Ellipsis and the Licensor will be individually referred to as a “Party,” and collectively as the “Parties.”
